The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV.
Treatments for hbv: A glimpse into the future / Bartoli, A.; Gabrielli, F.; Tassi, A.; Cursaro, C.; Pinelli, A.; Andreone, P.. - In: VIRUSES. - ISSN 1999-4915. - 13:9(2021), pp. 1767-N/A. [10.3390/v13091767]
Treatments for hbv: A glimpse into the future
Bartoli A.;Gabrielli F.;Cursaro C.;Pinelli A.;Andreone P.
2021
Abstract
The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV.
| File | Dimensione | Formato | |
|---|---|---|---|
|
viruses-13-01767-v2.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
893.08 kB
Formato
Adobe PDF
|
893.08 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
